[Clinical significance of two-tier grading system of ovarian serous carcinoma].
Jing
J
Zhang
Xiao-qing
XQ
Guo
Jing-song
JS
Liu
D000368:Aged; D014408:Biomarkers, Tumor / Q000378:metabolism; D002467:Cell Nucleus / Q000473:pathology*; D018284:Cystadenocarcinoma, Serous / Q000145:classification / Q000235:genetics / Q000473:pathology* / Q000628:therapy; D005260:Female; D019398:Genes, BRCA1; D024522:Genes, BRCA2; D006801:Humans; D008875:Middle Aged; D009154:Mutation; D009367:Neoplasm Staging; D010051:Ovarian Neoplasms / Q000145:classification / Q000235:genetics / Q000473:pathology* / Q000628:therapy; D011230:Precancerous Conditions / Q000235:genetics / Q000473:pathology; D011379:Prognosis; D015203:Reproducibility of Results; D015996:Survival Rate; D016159:Tumor Suppressor Protein p53 / Q000378:metabolism*
D014408:Biomarkers, Tumor; D016159:Tumor Suppressor Protein p53